Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Repasky

Showing results (231-240 of 355) with videos related to

Pageof 36
Sort By:
Journal of Emergency Nursing|April 5, 2014
Bedside management considerations in the treatment of pit viper envenomationSusan Smith, Susan S Sammons, Jennifer Carr, et al.
Gynecologic Oncology|November 3, 2005
Expression of Wilms tumor gene (WT1) in epithelial ovarian cancerBonnie Hylander, Elizabeth Repasky, Protul Shrikant, et al.
Clinical and Translational Medicine|August 22, 2022
Manipulating adrenergic stress receptor signalling to enhance immunosuppression and prolong survival of vascularized composite tissue transplantsMinhyung Kim, Daniel T Fisher, Paul N Bogner, et al.
JMIR Formative Research|July 31, 2025
Factors Associated With Portal and Telehealth Uptake and Use in a Minoritized, Low-Income Community: Mixed Methods StudyRobin T Higashi, Emily C Repasky, Antara Gupta, et al.
Cancer Research|July 3, 2004
Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikisLynn B Eckert, Gretchen A Repasky, Aylin S Ulkü, et al.
Combinatorial Chemistry & High Throughput Screening|December 6, 2014
Discovery of MINC1, a GTPase-activating protein small molecule inhibitor, targeting MgcRacGAPArjan J van Adrichem, Annika Fagerholm, Laura Turunen, et al.
Journal of Leukocyte Biology|August 30, 2011
Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermiaThomas A Mace, Lingwen Zhong, Casey Kilpatrick, et al.
British Journal of Cancer|December 12, 2013
Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical modelsH Zhang, B L Hylander, C LeVea, et al.
Cancer Research|March 26, 2002
Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110Masoud H Manjili, Robert Henderson, Xiang-Yang Wang, et al.
Pancreas|February 13, 2014
Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapyRohit Sharma, Sandra Buitrago, Rose Pitoniak, et al.
Pageof 36

Showing results (231-240 of 355) with videos related to

Sort By:
Pageof 36
Journal of Emergency Nursing|April 5, 2014
Bedside management considerations in the treatment of pit viper envenomationSusan Smith, Susan S Sammons, Jennifer Carr, et al.
Gynecologic Oncology|November 3, 2005
Expression of Wilms tumor gene (WT1) in epithelial ovarian cancerBonnie Hylander, Elizabeth Repasky, Protul Shrikant, et al.
Clinical and Translational Medicine|August 22, 2022
Manipulating adrenergic stress receptor signalling to enhance immunosuppression and prolong survival of vascularized composite tissue transplantsMinhyung Kim, Daniel T Fisher, Paul N Bogner, et al.
JMIR Formative Research|July 31, 2025
Factors Associated With Portal and Telehealth Uptake and Use in a Minoritized, Low-Income Community: Mixed Methods StudyRobin T Higashi, Emily C Repasky, Antara Gupta, et al.
Cancer Research|July 3, 2004
Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikisLynn B Eckert, Gretchen A Repasky, Aylin S Ulkü, et al.
Combinatorial Chemistry & High Throughput Screening|December 6, 2014
Discovery of MINC1, a GTPase-activating protein small molecule inhibitor, targeting MgcRacGAPArjan J van Adrichem, Annika Fagerholm, Laura Turunen, et al.
Journal of Leukocyte Biology|August 30, 2011
Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermiaThomas A Mace, Lingwen Zhong, Casey Kilpatrick, et al.
British Journal of Cancer|December 12, 2013
Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical modelsH Zhang, B L Hylander, C LeVea, et al.
Cancer Research|March 26, 2002
Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110Masoud H Manjili, Robert Henderson, Xiang-Yang Wang, et al.
Pancreas|February 13, 2014
Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapyRohit Sharma, Sandra Buitrago, Rose Pitoniak, et al.
Pageof 36